← Eichor
Study identifier: NCT06371352 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression

Condition: Unipolar Depression · Bipolar Disorder  ·  Sponsor: Jakub Antczak

PhaseNA
Planned participants90
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Intermittent and continuous theta-burst stimulation (iTBS and cTBS respectively) are the newer modalities of transcranial magnetic stimulation with documented efficacy in treatment of depressed mood but with conflicting results regarding their efficacy in treatment of other symptoms of depression such as insomnia, daytime sleepiness and fatigue. This study will investigate the efficacy of iTBS over the left dorsolateral prefrontal cortex (DLPFC) and cTBS over the right DLPFC, compared to sham stimulation, in treatment of insomnia, daytime sleepiness and fatigue in depression.

This description comes directly from the study's public registry record.

Talk to the study team

Bogdan Stefanowski, MD  ·  +48 22 45 82 532  ·  bstefanowski@ipin.edu.pl

Jakub Antczak, MD  ·  +48 12 400 25 50  ·  jakub.antczak@uj.edu.pl

Always discuss trial participation with your own doctor first.

Locations (1)

Institute of Psychiatry and NeurologyWarsaw, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06371352